Category: Hot News

The Selection Process for the 2025 TIME100

As journalists, the most frequent question we face, particularly now, is: what’s next? As we finalized this issue, President Trump’s tariff plan disrupted the economy. Many readers felt this accelerated a widespread shift with significant consequences. Reactions are mixed, and

More

Pfizer Halts Obesity Pill Development

` tags: “`xml Pfizer is halting the development of its experimental once-a-day obesity pill, even after starting extensive and costly clinical trials. The pharmaceutical company announced on Tuesday that it will discontinue studies on danuglipron due to a trial participant

More